|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Akero Therapeutics (NASDAQ: AKRO) through any online brokerage.
The latest price target for Akero Therapeutics (NASDAQ: AKRO) was reported by Morgan Stanley on March 23, 2021. The analyst firm set a price target for 63.00 expecting AKRO to rise to within 12 months (a possible 123.96% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Akero Therapeutics (NASDAQ: AKRO) is $28.13 last updated Today at 2:08:53 PM.
There are no upcoming dividends for Akero Therapeutics.
Akero Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Akero Therapeutics.
Akero Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.